Insights

​NEWS

Discover research updates, industry trends, and news contributing to progress in on-body drug delivery systems

10 January 2025

We’re proud to share that our On-Body Autoinjector has just been filed for patent in Australia! This milestone reflects our unwavering commitment to advancing innovative drug delivery solutions that improve patient care. We’re actively pursuing additional patent filings across global markets to broaden our impact and bring this breakthrough technology to more people worldwide. Thank you for supporting our mission to deliver cutting-edge healthcare solutions and transform the future of patient-centered therapies.

10 May 2025

Phase 1 Development Underway

We’ve officially kicked off Phase 1 of development for our Minimal Product Viability (MVP) design. This initial phase focuses on creating a cost-efficient, ISO 13485-compliant embedded electronic system for our wearable injector. The system is engineered to deliver 20 mL of subcutaneous medication over 60 minutes, prioritizing low complexity and affordability while enabling pilot testing and validation of core functions.

20 February 2026

‍Patent granted

Mincle Co Pty Ltd has been granted Australian Patent 2025220798 by IP Australia for its innovative wearable auto-injector technology. The patent, granted on 19 February 2026, covers a novel injection assembly designed to enhance usability and reliability in wearable drug delivery systems. This milestone reinforces Mincle’s position at the forefront of next-generation medical device innovation.

25 February 2026

Mincle Advances Global Protection with PCT Filing

Mincle Co Pty Ltd has filed an international patent application under the PCT for its wearable auto-injector technology. The filing supports protection across global markets and strengthens its IP strategy. It reflects continued innovation in the injection assembly and wearable device platform. This step positions Mincle for future international growth and partnerships.

08 May 2026

Mincle Co is proud to announce that our divisional Australian patent application covering innovations in a new engineered vented surface mat for mammalian cell lines and an innovative laboratory bench mat has officially been accepted by IP Australia.

This milestone recognises the innovation behind our mat systems designed to improve safety, airflow, cleanliness, and functionality in laboratory environments.

We’re excited to continue developing practical innovations for laboratories and technical workspaces worldwide.

Publications

PUBLICATIONS

Springer Nature Biomedical & Life Sciences,

Wearable Devices for Subcutaneous Delivery of Large‑Volume Biologics: Design, Use, and Regulatory Perspective Noelle Sunstrom2 · Frédérique N. Sunstrum1 Received: 22 May 2025 / Accepted: 23 July 2025